• Chlamydia Pneumoniae, Molecular
  • Clorazepate, Urine
  • Cephalosporin IgE
  • WIPF1 Gene Mutation Analysis
  • Helicobacter pylori Antibody, IgA
  • Herpes Simplex Virus (HSV) 1 and 2 Antigen, Immunofluorescent
  • Immunoglobulin A (IgA)
  • Alpha Fetoprotein (AFP), Body Fluid
  • Hereditary Colon Cancer Gene Mutation Panel (Lynch syndrome), NGS
  • Lipase, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Overview
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.